These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17316431)

  • 61. Calculating disability-adjusted-life-years lost (DALYs) in discrete-time.
    Larson BA
    Cost Eff Resour Alloc; 2013 Aug; 11(1):18. PubMed ID: 23927817
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review.
    Shroufi A; Chowdhury R; Anchala R; Stevens S; Blanco P; Han T; Niessen L; Franco OH
    BMC Public Health; 2013 Mar; 13():285. PubMed ID: 23537334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis.
    Ekwunife OI; Okafor CE; Ezenduka CC; Udeogaranya PO
    Cost Eff Resour Alloc; 2013 Jan; 11(1):2. PubMed ID: 23343250
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.
    Mori AT; Robberstad B
    BMC Med Inform Decis Mak; 2012 Sep; 12():110. PubMed ID: 23016739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania.
    Robberstad B; Hemed Y; Norheim OF
    Cost Eff Resour Alloc; 2007 Feb; 5():3. PubMed ID: 17316431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
    Lopez AD; Mathers CD; Ezzati M; Jamison DT; Murray CJ
    Lancet; 2006 May; 367(9524):1747-57. PubMed ID: 16731270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The polypill: at what price would it become cost effective?
    Franco OH; Steyerberg EW; de Laet C
    J Epidemiol Community Health; 2006 Mar; 60(3):213-7. PubMed ID: 16476750
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polypill holds promise for people with chronic disease.
    Wise J
    Bull World Health Organ; 2005 Dec; 83(12):885-7. PubMed ID: 16462975
    [No Abstract]   [Full Text] [Related]  

  • 75. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries.
    Robberstad B; Strand T; Black RE; Sommerfelt H
    Bull World Health Organ; 2004 Jul; 82(7):523-31. PubMed ID: 15500284
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.